Skip to main content
Log in

Profiling Breast Cancer by Array CGH

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Breast tumors display a wide variety of genomic alterations. This review focuses on DNA copy number variations in these tumors as measured by the recently developed microarray-based form of comparative genomic hybridization. The capabilities of this new technology are reviewed. Initial applications of array CGH to the analysis of breast cancer, and the mechanisms by which the particular types of copy number changes might arise are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Loeb LA: A mutator phenotype in cancer. Cancer Res 61: 3230-3239, 2001

    Google Scholar 

  2. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992

    Google Scholar 

  3. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407, 1997

    Google Scholar 

  4. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, KuoW-L, Chen C, Zhai Y, Dairkee SH, Ljung B-M, Gray JW, Albertson DG: Quantitative high resolution analysis of DNA copy number variation in breast cancer using comparative genomic hybridization to DNA microarrays. Nat Genet 20: 207-211, 1998

    Google Scholar 

  5. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46, 1999

    Google Scholar 

  6. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG: Assembly of microarrays for genome-wide measurement of DNA copy number by CGH. Nat Genet 29: 263-264, 2001

    Google Scholar 

  7. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G: Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl. Acad. Sci. USA 96: 4494-4499, 1999

    Google Scholar 

  8. Snijders AM, Segraves R, Blackwood S, Pinkel D, Albertson DG: BAC microarray-based comparative genomic hybridization. In: Zhao S, Stodolsky M (eds), Bacterial Artificial Chromosomes: Methods and Protocols, Methods in Molecular Biology, Humana Press, 2002 (in press)

  9. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo W-L, Gray JW, Pinkel D: Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25: 144-146, 2000

    Google Scholar 

  10. Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar A: Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58: 3237-3242, 1998

    Google Scholar 

  11. Pauletti G, Godolphin W, Press MF, Slamon DJ: Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 63-72, 1996

    Google Scholar 

  12. Hosokawa Y, Arnold A: Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22: 66-71, 1998

    Google Scholar 

  13. Waldman FM, DeVries S, Chew KL, Moore II DH, Kerlikowske K, Ljung BM: Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 92: 313-320, 2000

    Google Scholar 

  14. Muleris M, Dutrillaux AM, Olschwang S, Salmon RS, Dutrillaux B: Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer 14: 223-226, 1995

    Google Scholar 

  15. Kuo MT, Vyas RC, Jiang L-X, Hittelman WN: Chromosomal breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol 14: 5202-5211, 1994

    Google Scholar 

  16. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M: Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89: 215-225, 1997

    Google Scholar 

  17. Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR: MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol 18: 536-545, 1998

    Google Scholar 

  18. Paulson TG, Almasan A, Brody LL, Wahl GM: Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol Cell Biol 18: 3089-3100, 1998

    Google Scholar 

  19. Pipiras E, Coquelle A, Bieth A, Debatisse M: Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J 17: 325-333, 1998

    Google Scholar 

  20. Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B: A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1: 89-97, 2002

    Google Scholar 

  21. Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M: Double-strand breaks and tumorigenesis. Trends Cell Biol 11: S52-S59, 2001

    Google Scholar 

  22. Forsyth NR, Wright WE, Shay JW: Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69: 188-197, 2002

    Google Scholar 

  23. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T: Mammalian telomeres end in a large duplex loop. Cell 97: 503-514, 1999

    Google Scholar 

  24. Riboni R, Casati A, Nardo T, Zaccaro E, Ferretti L, Nuzzo F, Mondello C: Telomeric fusions in cultured human fibroblasts as a source of genomic instability. Cancer Genet Cytogenet 95: 130-136, 1997

    Google Scholar 

  25. McClintock B: Spontaneous alterations in chromosome size and form in Zea mays. Cold Spring Harb Symp Quant Biol 9: 72-81, 1941

    Google Scholar 

  26. Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung B-M, Waldman FM: Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 32: 292-296, 2001

    Google Scholar 

  27. Tsarouha H, Pandis N, Bardi G, Teixeira MR, Andersen JA, Heim S: 1999. Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality. Cancer Genet Cytogenet 113: 156-161, 1998

    Google Scholar 

  28. Waldman FM, Hwang ES, Etzell J, Eng C, DeVries S, Bennington J, Thor A: Genomic alterations in tubular breast carcinomas. Hum Pathol 32: 222-226, 2001

    Google Scholar 

  29. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F: Whole-arm t(1;16) and I(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer 5: 235-238, 1992

    Google Scholar 

  30. Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M: DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 89: 121-128, 2000

    Google Scholar 

  31. Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB, Ehrlich M: Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 77: 833-838, 1998

    Google Scholar 

  32. Brinkley BR: Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11: 18-21, 2001

    Google Scholar 

  33. Lingle WL, Barret SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL: Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99: 1978-1983, 2002

    Google Scholar 

  34. Oki E, Oda S, Maehara Y, Sugimachi K: Mutated genespecific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncogene 18: 2143-2147, 1999

    Google Scholar 

  35. Tlsty TD: Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc Natl Acad Sci USA 87: 3132-3136

  36. Rizki A, Lundblad V: Defects in mismatch repair promote telomerase-independent proliferation. Nature 411: 713-716, 2001

    Google Scholar 

  37. Henson JD, Neumann AA, Yeager TR, Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene 21: 598-610, 2002

    Google Scholar 

  38. Baselga J:Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials. Oncology 61Suppl 2: 14-21, 2001

    Google Scholar 

  39. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, King W: The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2: 116-123, 2000

    Google Scholar 

  40. Bastian BC, Wesselmann U, Pinkel D, Leboit PE: Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 113: 1065-1069, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albertson, D.G. Profiling Breast Cancer by Array CGH. Breast Cancer Res Treat 78, 289–298 (2003). https://doi.org/10.1023/A:1023025506386

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023025506386

Navigation